All In Biotech

Drug Trial Radar · NCT06582524

Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency

A Phase 3 Open-Label Study of Safety, Pharmacokinetics, and Activity of Weekly Subcutaneous Pegzilarginase in Subjects <24 Months Old With Arginase 1 Deficiency

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

3

Actual

Start

Aug 30, 2024

Primary completion

Jun 17, 2025

Study completion Jun 17, 2025

Sponsor

Lead sponsor
Immedica Pharma ABIndustry
Sponsor type
Industry
First posted
Sep 3, 2024

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 1 day, up to 24 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, multicentre study to evaluate the safety, PK, and activity (PD) of weekly subcutaneous (SC) administration of pegzilarginase in subjects with ARG1-D who are \< 24 months of age. The study consists of a screening period of up to 4 weeks, a subsequent 12-week treatment period, and a safety follow-up period of 8 weeks.

Conditions

  • Arginase 1 Deficiency

Interventions

  • PegzilarginaseDrug

    SC administration of pegzilarginase over 12 weeks in subjects with ARG1-D who are \< 24 months of age

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in Plasma Arginine Concentrations in Subjects <24 Months of Age With Arginase 1 Deficiency (ARG1-D).Time frame: From baseline up to 12 weeks.

Locations

3 sites in 3 countries. Site status is shown where the registry gives one.

  • Univ. Klinik für Kinder- und Jugendheilkunde Medizinische Universität

    Graz, Austria

  • Unidade de Doenças Metabólicas Pediatria, Hospital Santa Maria

    Lisbon, Portugal

  • Bradford Royal Infirmary Duckworth Lane

    Bradford, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.